U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 51 - 60 of 215

Online Training Enables Primary Care Providers in Rural New Mexico to Prescribe Medication for Opioid Use Disorders

This case study highlights rural primary care practices in New Mexico that have expanded medication-assisted treatment to patients with opioid use disorder. The program is called MOUD ECHO, and is funded by the Agency for Healthcare Research and Quality (AHRQ).
Format
Web Page
Audience
States
Behavioral Health Providers
Medical Providers
Source
Agency for Healthcare Research and Quality
Year
Resource Type
Web Page

Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl

These guidelines provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids.

Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Provider Clinical Support System (PCSS)
Year
Resource Type
PDF
File Size
1646 KB

Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences (PRAPARE)

The Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences (PRAPARE) is a national standardized tool designed to help healthcare providers assess and address the social determinants of health (SDOH) affecting their patients.

Format
Instrument/Protocol
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
National Association of Community Health Centers
Year
Resource Type
PDF
File Size
282 KB

Requirements for training for Medication Assisted Treatment as part of the MATE Act

This letter announces details on the 2023 Medication Access and Training Expansion (MATE) Act which requires new or renewing DEA licensees to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
PDF
File Size
245 KB

SUD 101 Core Curriculum

The modules in the curriculum provide an overview of evidence-based practices in the prevention, identification, and treatment of substance use disorders and co-occurring medical and psychiatric conditions for a variety of populations.

Format
Curriculum
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Providers Clinical Support System (PCSS)
Year
Resource Type
Web Page

The Role of Low-Threshold Treatment for Patients with Opioid Use Dusirder (OUD) in Primary Care

This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Agency of Healthcare Quality and Research (AHRQ) Integration Academy
Year
Resource Type
Web Page

Wounds, Withdrawal, and Overdose: What to Expect from Xylazine Drug Supply Adulteration

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the pharmacology, toxicology, diagnostic testing, and epidemiology of xylazine in exposures. The session includes didactic content, case-based narrative, review of literature, and panel discussion to review important topics about the emerging xylazine crisis in the US.
Format
Web-Based Course
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine (ASAM)
Year
Resource Type
Video